FDA Drug Application (022048) for TRIESENCE by ALCON

Back to FDA Applications sponsored by ALCON

Application Number022048
Product Number001
FormINJECTABLE;INTRAVITREAL
Dosage40MG/ML (40MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRIESENCE
Active IngredientTRIAMCINOLONE ACETONIDE

Active IngredientCount
List of drugs with Active Ingredient TRIAMCINOLONE ACETONIDE33


Back to FDA Applications sponsored by ALCON